29/06/2011 23:30PM Australia/Sydney
RESEARCH TRIANGLE PARK, N.C. (BUSINESS WIRE)
Consulting at Quintiles Details Benefits of a Sustainable
Elevating compliance to achieve a strategic advantage going beyond
just meeting regulatory requirements for an innovative drug, biologic or
medical device allows biopharmaceutical companies to respond more
rapidly to ever-changing conditions in the New
Health, according to a new report from Consulting
Art of Compliance: Turning Compliance into Sustainable Business Advantage
offers a fresh approach to help biopharmaceutical companies achieve
quality and compliance improvements based on a compliance maturity
curve. The compliance maturity curve moves from Stage 1, where the
compliance model is essentially broken, through improvements in
compliance and performance to Stage 4, where a sustainable,
process-driven compliance system is in place.
Best-in-class compliance can help biopharma firms achieve market
differentiation by building a reputation for superior product and
service quality and by avoiding the need for spending on reactive
compliance, said Robert A. Rhoades, Vice President, Quality and
Compliance. Sustainable compliance can profoundly affect the financial
health of an enterprise.
The report describes various approaches to compliance and illustrates
how companies can move from a traditional approach to a more sustainable
compliance framework that is efficient and fully integrated with key
business processes. The analysis follows a spike in Food and Drug
Administration enforcement activity, including record numbers of Warning
Sustainable compliance is not just nirvana for the process gurus; its
an imperative, Rhoades said. The best time to take action on
compliance is before problems arise. Done poorly, it can mean
interruption of supply to customers, long-term decline of a firms
credibility and the ultimate demise of the business enterprise. Done
well, it provides a competitive advantage, growth and financial health.
About Consulting at Quintiles
Consulting at Quintiles delivers breakthrough thinking built on decades
of industry experience. It helps customers optimize the clinical
development process, access markets more effectively, maximize
commercial performance over the lifecycle, mitigate regulatory
compliance risks and validate and strengthen portfolio strategy.
Consulting at Quintiles brings a critical element to engagements: fresh
thinking built on a full lifecycle understanding of biopharma realities
that draws on expertise from the Clinical, Commercial and Capital groups
of Quintiles. For more information, please visit www.quintiles.com/consulting.
Quintiles is the only fully integrated biopharmaceutical services
company offering clinical, commercial, consulting and capital solutions
worldwide.†The Quintiles network of more than 20,000 engaged
professionals in 60 countries around the globe works with an unwavering
commitment to patients, safety and ethics.†Quintiles helps
biopharmaceutical companies navigate risk and seize opportunities in an
environment where change is constant. For more information, please visit www.quintiles.com.